The QualityStocks Daily Stock List
- Investview, Inc. (INVU)
- Rocky Mountain High Brands, Inc. (RMHB)
- Teranga Gold Corporation (TGCDF)
- BioCorRx, Inc. (BICX)
- Helix TCS, Inc. (HLIX)
- Noble Roman’s, Inc. (NROM)
- Precision Optics Corp., Inc. (PEYE)
- MRI Interventions, Inc. (MRIC)
- Blox, Inc. (BLXX)
- Delcath Systems, Inc. (DCTH)
- Blue Line Protection Group, Inc. (BLPG)
- Table Trac, Inc. (TBTC)
- SANUWAVE Health, Inc. (SNWV)
- WRIT Media Group, Inc. (WRIT)
Investview, Inc. (INVU)
Stock Deputy, Morningstar, Stockopedia, Stockflare, Investopedia, Stockhouse, MarketWatch, Barchart, InvestorsHub, Marketwired, last10k, Infront Analytics, Capital Cube, OTC Markets, The Street, Proactive Investors, Trading View, Stockwatch, and Guru Focus reported earlier on Investview, Inc. (INVU), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Investview, Inc. is a diversified financial technology company based in Salt Lake City, Utah. It operates primarily through its wholly- and majority-owned subsidiaries. Investview provides financial products and services to accredited investors, self-directed investors, and select financial institutions. The Company has its Wealth Generators wholly-owned subsidiary that has undergone a name change. Investview lists on the OTCQB.
Investview announced in March of 2018 that it filed a name change for its wholly-owned subsidiary Wealth Generators LLC to Kuvera LLC. Investview changed the name of Wealth Generators to Kuvera LLC in its first steps to create its vision for its previously acquired LLC. Investview released the Kuvera brand in the final transition steps to rename its wholly-owned subsidiary Wealth Generators LLC to Kuvera LLC. Investview completed the transition on April 12, 2018 when it unveiled the Kuvera brand through a series of live launch webinars, the release of kuveraglobal.com and a complete set of marketing tools to share the Kuvera vision and mission.
In essence, Investview provides education and technology designed to help individuals in navigating the financial markets. Its services include tools and research, newsletter alerts, and live education rooms that consist of instruction on the subjects of equities, options, FOREX, ETF’s, and binary options.
The Company also offers education and technology applications to help individuals in debt reduction, enhanced savings, budgeting, and proper tax expense management. Investview has added Crypto mining services and education to its program services.
Investview entered into an agreement with BYOBitcoin LLC. This agreement is to provide mining hardware, software and services for Bitcoin mining. Investview’s ability to provide a turn-key hardware and services package permits individuals to participate in what has become a technology sector primarily controlled by large players who can establish huge mining farms.
Investview officially launched Kuvera France in Paris on Sunday, January 6, 2019. Kuvera France is a wholly-owned subsidiary of Investview that was established in late 2018 to handle the considerable demand for Kuvera financial education products in the European Union (EU), with the strongest demand in France.
Investview has entered a definitive material agreement with Triton Funds, LP in a strategic financial arrangement that enables growth and expansion for the Company’s financial product education used mainly by millennials. On December 29, 2018, Investview entered into a Common Stock Purchase Agreement, a Registration Rights Agreement, and a Share Donation Agreement with Triton Funds, LP, a Delaware Limited Partnership, a non-affiliate of the company.
Since inception, the overwhelming majority of the Kuvera customer base is millennials. Kuvera’s growth is stimulated by this demographic and the Company’s top distributors are under the age of 30. Kuvera provides affordable access to valuable financial education, current market research and leading-edge technology. Kuvera products undergo distribution by way of a direct sales model. Product services are offered to individuals on a monthly subscription basis.
Moreover, Investview has entered the automated trading industry via its wholly-owned subsidiary SAFE Management LLC. Investview entered the trade automation space with the launch of two new robo trading products offered through its wholly-owned Registered Investment Advisor: Safe Management, and made available to customers of Kuvera financial education services.
Investview, Inc. (INVU), closed Tuesday's trading session at $0.019, down 4.04%, on 55,827 volume with 8 trades. The average volume for the last 3 months is 183,639 and the stock's 52-week low/high is $0.0042/$0.0675.
Rocky Mountain High Brands, Inc. (RMHB)
Penny Picks, SizzlingStockPicks, WallstreetSurfers, ProTrader, Fortune Stock Alerts, SmallCapVoice, Promotion Stock Secrets, PennyPickAlerts, Damn Good Penny Picks, and Winston Small Cap reported previously on Rocky Mountain High Brands, Inc. (RMHB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Rocky Mountain High Brands, Inc. is a consumer goods business listed on the OTC Markets’ OTCQB. The Company’s specialty is brand development of health conscious, hemp-infused, food and beverage products and naturally high alkaline water. Rocky Mountain High Brands has launched its naturally high alkaline spring water, Eagle Spirit Spring Water. The Company is based in Dallas, Texas.
Rocky Mountain High Brands has acquired all of the assets, trademarks, intellectual property (IP) and ongoing business operations of BFIT Brands, LLC of Phoenix, Arizona. BFIT Brands sells the whey protein and energy drink, FitWhey.
Rocky Mountain High Brands currently markets a lineup of two naturally flavored hemp-infused functional beverages under the name Rocky Mountain High. Regarding its Eagle Spirit Spring Water, it is a naturally high alkaline spring water from a secluded spring at the foot of the ancestral Rocky Mountains.
Rocky Mountain High Brands has launched its HEMPd Infusion Flavored Waters on its www.HEMPd.com website. It has four flavors of HEMPd Infusion Flavored Waters. These are Raspberry Lemonade, Peach Mango, Dragon Fruit, and Pineapple Coconut and each contains 5 mg of full plant cannabidiol (CBD).
Rocky Mountain High Brands has been granted permission to be the sole provider of high-quality drinks containing CBD to sell throughout Mexico by RCH Grupo’s subsidiary, CBD Life. It is the first time a U.S. company has manufactured a hemp product in the form of beverages for sale in Mexico.
Recently, Rocky Mountain High Brands announced an update on its agreement with CBD Life, a subsidiary of RCH Grupo. On December 28, 2018, the Company received the initial purchase order and deposit from CBD Life for an initial test run of 2,000,000 cans of Rocket High, California Lemonade and California Black Tea.
On January 15, 2019, representatives of CBD Life met with Rocky Mountain High Brands Officers at their Corporate Headquarters in Dallas. The purpose of the meeting was for the representatives to gain an understanding of Rocky Mountain High’s status on the initial purchase order for CBD Life and to set expectations for purchase orders to follow throughout the rest of 2019.
Rocky Mountain High Brands, Inc. (RMHB), closed Tuesday's trading session at $0.009, up 2.27%, on 11,288,348 volume with 209 trades. The average volume for the last 3 months is 11,439,926 and the stock's 52-week low/high is $0.0075/$0.018.
Teranga Gold Corporation (TGCDF)
The Street, Stockhouse, OTC Markets, 4-Traders, Capital Equity Review, Simply Wall St, Street Insider, InvestorsHub, The Northern Miner, 24hgold, Canadian Insider, Junior Mining Network, GuruFocus, YCharts, Investcom, and MarketWatch reported beforehand on Teranga Gold Corporation (TGCDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Teranga Gold Corporation is a multi-jurisdictional West African gold company listed on the OTCQX. Its emphasis is on production and development and the exploration of more than 6,400 km2 of land located on prospective gold belts. The Company is advancing its Wahgnion Gold Project, with an earlier released positive Feasibility Study (FS), and conducting extensive exploration programs in Burkina Faso, Senegal and Côte d’Ivoire. Teranga Gold is based in Toronto, Ontario.
The Company has close to 4.0 million ounces of gold reserves from its combined Sabodala Gold operations and Wahgnion Gold Project. Since its initial public offering (IPO) in 2010, Teranga Gold has produced greater than 1.4 million ounces of gold from its operations in Senegal, which as of June 30, 2017, had a reserve base of 2.7 million ounces of gold.
Teranga Gold owns and operates the Sabodala Gold mine, which is the only gold mine and mill in Senegal, West Africa. This mine is roughly 650 km southeast of Dakar, the capital of Senegal. Sabodala has been in operation since 2009. The Sabodala Mining Concession and the surrounding exploration permits are positioned within the highly prospective Kedougou-Kenieba Inlier that forms part of the Paleoproterozoic age Birimian Terrane of the West African Craton.
In October of 2016, the Banfora Gold Project was acquired as part of Teranga Gold’s acquisition of Gryphon Minerals. The fully permitted, high-grade, open pit Banfora Gold Project is in the southwest of Burkina Faso, West Africa. It is in a major gold producing district host to a number of first-rate gold deposits. Teranga Gold owns 90 percent of the Project. The Burkina Faso government owns the remaining 10 percent.
Teranga Gold has acquired the remaining 49 percent interest in the Golden Hill and Gourma projects from Boss Resources Limited. Teranga previously had the right to increase its 51 percent stake and earn up to an 80 percent interest in each project upon delivery of an FS on either project and the payment of AUD2.5 million. With the transaction, Teranga Gold owns a 100 percent interest in each of the Golden Hill and Gourma projects in Burkina Faso, West Africa.
Last week, Teranga Gold announced an initial mineral resource estimate for its Golden Hill advanced exploration project, situated within the central part of the highly mineralized Houndé Greenstone Belt in southwest Burkina Faso, West Africa. Golden Hill resource estimate highlights include Indicated mineral resources of 6.40Mt averaging 2.02 g/t gold for 415,000 ounces. Highlights also include Inferred mineral resources of 11.95Mt averaging 1.68 g/t gold for 644,000 ounces. There is excellent along trend and to-depth continuity of gold mineralization at all prospects drilled.
Additionally, last week, Teranga Gold reported its operating and financial results for the three and twelve months ended December 31, 2018. The Company also provided an update on the development of its second mine, Wahgnion Gold Operations. Operating highlights include record full-year gold production of 245,230 ounces, surpassing the high end of the Company’s increased 2018 production guidance range of 235,000-240,000 ounces.
Wahgnion Gold Operations achieved significant construction project milestones in 2018. It is on track for first gold pour and ramp up to nameplate production in Q4 2019. It increased open-pit mineral reserves by approximately 40 percent to 1.6 million ounces. Moreover, Wahgnion increased mine life to 13 years and improved first five years’ production and cost profile.
Teranga Gold Corporation (TGCDF), closed Tuesday's trading session at $3.25, down 5.25%, on 19,636 volume with 63 trades. The average volume for the last 3 months is 21,424 and the stock's 52-week low/high is $2.40/$4.325.
BioCorRx, Inc. (BICX)
Stockhouse, InvestorsHub, Equity Clock, Equity Observer, TMXmoney, OTPicks, Massive Stock Profits, Stockwatch, The Street, Barchart, Buyins.net, PrePump Stocks, Penny Picks, Damn Good Penny Picks, Penny Stock Newsletter, SmallCapVoice, Value Penny Stocks, and PennyStocks24 reported beforehand on BioCorRx, Inc. (BICX), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
BioCorRx, Inc. is a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. It provides an innovative approach to the treatment of substance abuse addiction and has its BioCorRx® Recovery Program. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program. The Company’s emphasis is on improving the quality of life for recovering addicts. BioCorRx Pharmaceuticals is the Company’s research and development (R&D) subsidiary. BioCorRx has its corporate headquarters in Anaheim, California.
The BioCorRx® Recovery Program consists of two principal components. The first component comprises an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist, which can considerably reduce physical cravings for alcohol and opioids.
The second component is a one-on-one proprietary counseling program. It is mainly tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments. BioCorRx has also expanded the support structure to include 12 months of a peer-support system using trained recovery specialists. Moreover, it is developing a patent pending injectable form of naltrexone.
BioCorRx® has submitted a grant application to the National Institutes of Health (NIH) to fund the development and study plans for BICX102. This is the Company’s single administration, multi-month sustained release naltrexone implant for the treatment of opioid and alcohol use disorders.
At present, the BioCorRx Pharmaceuticals subsidiary is developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd. BICX101 is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. BioCorRx’s plan is to seek Food and Drug Administration (FDA) approval for BICX101 and/or its naltrexone implant product(s).
Last month, BioCorRx announced that it was awarded a 2-year grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under award number UG3DA047925 for the development of BICX102. BioCorRx is seeking FDA approval for BICX102.
Last week, BioCorRx announced the formation of its Scientific Advisory Board (SAB) with three key appointments. These appointments are David R. Gastfriend, M.D., DFASAM, Evgeny Krupitsky M.D., Ph.D., D.M.Sc., and George E. Woody, M.D. The SAB will work closely with the Company’s management team as it continues to advance its lead product candidate, BICX102.
BioCorRx, Inc. (BICX), closed Tuesday's trading session at $4.50, even for the day, on 2,659 volume with 14 trades. The average volume for the last 3 months is 141,919 and the stock's 52-week low/high is $4.17/$10.00.
Helix TCS, Inc. (HLIX)
Green Market Report, Awesome Penny Stocks, Stockhouse, Dividend Investor, MarketWatch, InvestorsHub, Stock Daily Review, The Street, The Daily Marijuana Observer, Insider Financial, Market Screener, Stockopedia, Stockwatch, Uptick News Wire, Marketwired, The Stock Rover, Market Exclusive, Simply Wall St, and Business Insider reported earlier on Helix TCS, Inc. (HLIX), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Helix TCS, Inc. is a provider of integrated operating environment solutions for the legal cannabis Industry. The Company has acquired Cannabase, which is the oldest and largest wholesale platform in the cannabis industry. Helix TCS’ mission is to provide clients with the most powerful and innovative integrated operating environments in the market. This is to help clients better manage and reduce risk while they focus on their core business. BioTrackTHC is a wholly-owned subsidiary of Helix TCS. Helix TCS is headquartered in Greenwood Village, Colorado.
Helix TCS provides a technology platform that enables clients to manage inventory and supply costs through Cannabase. The Company’s services include Technology, Compliance, and Security.
Regarding Security, Helix TCS offers Transport, Armed and Unarmed Guarding, Training, Investigation, and Special Services. Security is its flagship service offering. Concerning Compliance, Helix TCS has a broad array of compliance services for companies in the Cannabis Industry. This safeguards clients’ ability to operate while increasing their access to services.
In 2017, the Company acquired Security Grade Protective Services, Ltd. Security Grade operates as a wholly-owned subsidiary of Helix TCS. Security Grade is a Denver, Colorado-based security firm that provides a range of custom, full-service security solutions to cannabis business customers.
Helix TCS, with its strategic capital partner, Rose Capital, announced in June 2018 the closing of its merger with Bio-Tech Medical Software, Inc. (dba BioTrackTHC). The merger closed on June 1, 2018. Bio-Tech Medical Software, via its BioTrackTHC division, develops and licenses product traceability, inventory management, and Point-of-Sale (POS) software systems for the developing medical and recreational cannabis industry.
Furthermore, Helix TCS acquired software development firm Engeni. This acquisition closed on August 3, 2018. Engeni, located in Buenos Aires, specializes in developing sales, marketing, and client service applications for SMEs in an assortment of languages. Engeni has been a strategic partner of Helix TCS since April of 2017.
Earlier this month, Helix TCS announced that it acquired Amercanex International Exchange. This one of the first and most influential cannabis electronic trading platforms in the legal cannabis industry. This acquisition provides Helix TCS with a sophisticated Electronic Communications Network (ECN) that can integrate blockchain technology to facilitate real-time transactions of wholesale cannabis product between licensed operators in regulated markets.
This acquisition further expands Helix TCS' Critical Infrastructure Services Platform. This platform enables new and already operating cannabis businesses, and also ancillaries and governments, to manage mission critical infrastructure in their supply chain, inventory, and compliance functions.
Moreover, this month, Helix TCS announced that its subsidiary, BioTrackTHC, was presented with an award for Excellence in Innovation in the category of Business Strategy and Innovation by the National Cannabis Industry Association (NCIA). NCIA is the largest and longest running non-profit association in the legal cannabis industry.
The award was presented February 14, 2019 during NCIA's Seed to Sale Show in Boston, Massachusetts. The Company was also recently recognized as the #1 revenue generating point of sale provider by Cannabis Business Executive and the leader in commercial dispensary point of sale market share by Cannabiz Media.
Helix TCS, Inc. (HLIX), closed Tuesday's trading session at $1.73, up 16.11%, on 274,352 volume with 451 trades. The average volume for the last 3 months is 31,768 and the stock's 52-week low/high is $0.771/$4.01.
Noble Roman’s, Inc. (NROM)
Simply Wall St, Taglich Brothers, SmallCapVoice, Insider Financial, Marketbeat, The Bowser Report, Wallet Investor, FeedBlitz, Equity Clock, Penny Stock Tweets, Stockopedia Penny Stock Hub, Investor Village, Tip Ranks, Stock Oodles, Wall Street Resources, YCharts, and MicroCapClub reported earlier on Noble Roman’s, Inc. (NROM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company’s business model consists of three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP) trade names. Noble Roman’s is headquartered Indianapolis, Indiana.
The Company has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. In addition, Noble Roman’s has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.
Concerning the Company’s three growth venues, Grocery Take-n-Bake Licensing involves licensing to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.
Pertaining to Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.
Regarding Non-Traditional Venues, these are typically located in a host facility whose chief business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit.
On January 31, 2017, the first Noble Roman's Craft Pizza & Pub (CPP) opened in Westfield, Indiana. In May of 2018, the Company announced that it opened a fourth location of its new-generation, stand-alone pizzeria concept, Noble Roman's Craft Pizza & Pub (CPP) in Carmel, Indiana.
Noble Roman’s intention is to expedite the development of Craft Pizza & Pub (CPP) locations via franchising. General franchising is planned for Indiana and surrounding areas with an emphasis on franchisees that can become multi-unit operators. Moreover, the Company will also pursue development of other markets deemed suitable for the concept with experienced multi-unit operators.
In January, Noble Roman's announced that it completed the roll-out of its new curbside carry-out service in all restaurant locations. The design of the Company's new curbside service for carry-out customers is to create added value and convenience. The program is called "Pizza Valet Service." With Pizza Valet Service, customers place orders ahead, drive into the restaurant's reserved valet parking spaces, and have their pizza run to their vehicle by specially uniformed pizza valets.
Additionally, in January, Noble Roman's announced that its first franchisees for Craft Pizza & Pub (CPP), Patrick and Holly O'Neil, signed a lease and entered into a construction contract for their first CPP restaurant in Lafayette, Indiana. Construction is now taking place. This location is scheduled for a grand opening by late March.
Noble Roman’s, Inc. (NROM), closed Tuesday's trading session at $0.50, even for the day, on 7,000 volume with 3 trades. The average volume for the last 3 months is 15,718 and the stock's 52-week low/high is $0.33/$0.855.
Precision Optics Corp., Inc. (PEYE)
MarketWatch, Stockhouse, Bull Trends, last10k, Morningstar, Investor Trendz, Penny Stock Scholar, OTCtipReporter, Small Cap Investor Daily, GuruFocus, Club Penny Stocks Network, Growing Stocks Reports, 4-Traders, Barchart, Research Driven Investor, Marketbeat, Pumps and Dumps, Michael Stone, Wallet Investor, and Infront Analytics reported previously on Precision Optics Corp., Inc. (PEYE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Precision Optics Corp., Inc., emoploying proprietary optical technologies, is a leading developer and manufacturer of advanced optical instruments. It designs and produces next generation medical instruments, Microprecision™ micro-optics with characteristic dimensions under 1 millimeter, and other advanced optical systems for a wide variety of customers. Precision Optics is based in Gardner, Massachusetts and lists on the OTC Markets’ OTCQB.
Precision Optics has expertise in providing lenses to sizes as small as 0.2mm in diameter using its proprietary Microprecision™ technology with the quality of ground lenses approaching the cost of gradient index (GRIN) lenses. The Company’s expertise includes the design, development, and manufacturing of optical and mechanical-optical components, sub-assemblies, and systems. These include lenses, prisms, thin film coatings, optical assemblies, sinuscopes, arthroscopes, laparoscopes, stereo-endoscopes, beamsplitters, endocouplers, camera adapters and fiber optic assemblies.
Precision Optics provides optical components, optical system design and production of different lens and prism products for the defense and aerospace industries. The Company’s belief is that current advances in its proprietary micro-optics and 3D imaging technologies present major opportunities for expanding applications to numerous potential medical products and procedures.
Regarding Micro-Optics & Components, Precision Optics has an in-house optical shop, flexible manufacturing, and a staff of highly trained optical designers and technicians. The Company can manufacture cost-effectively in prototype, low or high volumes.
Earlier this month, Precision Optics announced operating results on an unaudited basis for its fiscal year 2019 Q2 and six months ended December 31, 2018. The Company had Revenues of $1,478,000 in the quarter ended December 31, 2018 versus $813,000 in the same quarter of the prior year. This represents 82 percent growth.
It had Revenues of $3,037,000 in the six months ended December 31, 2018 versus $1,842,000 in the same six month period of the prior year. This represents 65 percent growth. Precision Optics had a 282 percent and 310 percent increase in production revenues in the quarter and six month periods ended December 31, 2018 versus the same periods of the prior year, and this drove Company-wide growth.
Precision Optics Corp., Inc. (PEYE), closed Tuesday's trading session at $1.45, down 3.33%, on 577 volume with 2 trades. The average volume for the last 3 months is 4,752 and the stock's 52-week low/high is $0.479/$1.85.
MRI Interventions, Inc. (MRIC)
NetworkNewsWire, Market Exclusive, Wall Street Resources, InvestorsHub, Real Pennies, Stockhouse, 4-Traders, and FeedBlitz reported on MRI Interventions, Inc. (MRIC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MRI Interventions, Inc. is a commercial stage medical device company. It develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain under direct, intra-procedural Magnetic Resonance Imaging, or MRI, guidance. Using a hospital's existing MRI suite, the design of its Food and Drug Administration (FDA)-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain. MRI Interventions is based in Irvine, California.
The Company’s focus is Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures. The ClearPoint® system enables real-time MRI-guided navigation for a broad array of minimally-invasive neurosurgery procedures.
The ClearPoint® system is the only navigation platform designed to allow real-time visualization during minimally-invasive neurosurgical procedures. The platform is particularly well-matched for facilitating drug delivery directly to brain tumors.
ClearPoint® is an integrated system of hardware components, disposable components, and intuitive, menu-driven software. The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be used with 1.5T and 3T scanners.
MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, regarding the ClearPoint® system. In addition, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.
Recently, MRI Interventions announced financial results for its second fiscal quarter ended June 30, 2018. Total Revenue for Q2 was $1.65 million. This represents a decrease of 17 percent in comparison to the prior year quarter.
Gross Margin increased to 63 percent for the quarter, versus 60 percent in the prior year quarter. Net Loss in Q2 2018 was $1.9 million, versus $2.0 million in the same period of 2017.
The Company received CE Mark approval for its SmartFlow® cannula for the indication of delivery of fluids to the brain, with the expectation of clinical use in Europe before the end of this year. MRI Interventions also submitted for FDA 510(k) Clearance for the ClearPoint 2.0 software platform upgrade and for the ClearPoint PURSUIT™ neuro-aspiration device developed in association with the Mayo Clinic.
MRI Interventions, Inc. (MRIC), closed Tuesday's trading session at $2.99, up 4.91%, on 5,043 volume with 16 trades. The average volume for the last 3 months is 9,437 and the stock's 52-week low/high is $1.33/$3.737.
Blox, Inc. (BLXX)
OTC Markets Group, SmallCapVoice, and PennyStocks24 reported earlier on Blox, Inc. (BLXX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Blox, Inc.’s vision is to pioneer the development of mining projects through applying green innovation to traditional mining methods and combining renewable energy and technology into the process. The OTCQB-listed Company’s plan is to become an international leader in the production of “green minerals”. Blox Minerals is a wholly-owned subsidiary of Blox, Inc. Blox is based in Vancouver, British Columbia.
An important element of Blox’s mandate is to implement clean energy into the mining process. This is to effectively “green” the mining process and minimize its environmental impact via lower hydrocarbon emissions. The Company’s plan is to build a portfolio of gold and other minerals and produce them in a socially and environmentally friendly manner.
Blox defines “green minerals” as minerals produced using technologies, best practices, and mine processes implemented to reduce the environmental impacts associated with the extraction and processing of metals and minerals. Its plan is to use renewable energy and technology in the production of green minerals with the goal of turning expensive costs into profits through utilizing renewable energy plants to power its different projects.
Blox’s key concession holdings are in Ghana and Guinea, West Africa. Its projects include Pramkese, Osenase, Asamankese, and Mansounia.
The Mansounia Exploration Licence is centered on Latitude 10º 23’ N and Longitude 9º 47’ W in the Kouroussa Prefecture, Kankan Region, in Guinea, West Africa. It covers a surface area of 145 square kms. At Mansounia, significantly fresh rock mineralization has been intersected and as of July 2016, remains unexplored. Mansounia is a priority development asset for Blox.
Blox has entered into a Strategic Alliance Agreement with Ashanti Sankofa, Inc. With the terms of the Strategic Alliance Agreement, both parties agreed to grant to the other party a right of first refusal to enter into a joint venture (JV) on any of their respective properties and/or projects and that any future acquisition of natural resource properties that may be acquired by either party that contains, but is not limited to, gold, precious metals, technology metals or diamonds (Natural Resource Properties), the acquiring party will grant to the other party a right of first refusal to participate in a JV on such Natural Resource Property that shall be at the sole discretion of the acquiring party.
Recently, Blox announced that a new drilling target was defined by a 2.5km long Gold in Soil anomaly, at its Mansounia Gold Project, in the highly prospective Siguiri Basin area of Eastern Guinea. This new drilling target was defined after a wide-ranging database compilation and exploration targeting exercise undertaken by Sahara Natural Resources on the historical data held by Blox in the region. Sahara defined a Gold in Soil geochemical anomaly over roughly a 2.5km strike. The anomaly is open and untested to the North and South.
Blox, Inc. (BLXX), closed Tuesday's trading session at $0.1499, up 49.90%, on 6,000 volume with 2 trades. The average volume for the last 3 months is 1,543 and the stock's 52-week low/high is $0.10/$0.30.
Delcath Systems, Inc. (DCTH)
OTC Markets, Barchart, Invest.com, Morningstar, Stock News Journal, Stocktwits, SuperStockScreener, StocksGallery, 4-Traders, TradingView, MarketWatch, and Insider Financial reported on Delcath Systems, Inc. (DCTH), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Delcath Systems, Inc. is an interventional oncology Company centered on the treatment of primary and metastatic liver cancers. Its investigational product is Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The design of this product is to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Delcath Systems has its corporate office in New York, New York. The Company lists on the OTCQB.
Delcath Systems has supported clinical research of liver directed high dose chemotherapy in patients with metastatic ocular and cutaneous melanoma, metastatic colorectal cancer, metastatic neuroendocrine tumors, and hepatocellular carcinoma. Liver directed high dose chemotherapy uses percutaneous hepatic perfusion (PHP) to deliver concentrated doses of a chemotherapeutic agent directly to the liver.
The Company’s system has been commercially available in Europe since 2012 under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a broad array of cancers of the liver.
Delcath is working on advancing its clinical programs of its unique Melphalan/HDS. Moreover, it is working to boost commercialization efforts for CHEMOSAT in Europe. It continues its focus on the clinical trials, which consist of the Clinical Development Program (CDP).
The Company has begun an international Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM). It plans to start a worldwide registration trial for intrahepatic cholangiocarcinoma (ICC). Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the United States.
Delcath Systems announced in May that it started its pivotal trial of Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) to treat patients with intrahepatic cholangiocarcinoma (ICC). Duke Medical Center in Durham, North Carolina is the first cancer center to open for patient enrolment. Dr. Sabino Zani is serving as the principal investigator for the trial in the United States. Dr. Zani is a surgical oncologist with Duke Medical Center.
Recently, Delcath Systems announced that it filed an amendment with the FDA to revise the protocol for its Phase 3 clinical trial in ocular melanoma liver metastases. With this amendment, the trial, now entitled, A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma, will enroll 80 patients with ocular melanoma metastatic to the liver.
On the whole, the enrollment of 80 patients represents a 66 percent reduction in trial size from the previous randomized trial that required 240 patients to reach statistical significance. Patients presently enrolled in the Melphalan/HDS arm of the trial under the prior randomized protocol will continue to be treated and evaluated as part of the amended trial. With the amendment, Delcath Systems anticipates completing trial enrollment by the end of the first half of 2019.
Recently, Delcath Systems announced that patient enrollment has started under the amended protocol for its registration trial in ocular melanoma liver metastases. Stanford University Medical Center is the first trial site to obtain Institutional Review Board (IRB) approval for the amended protocol. The Center is open to patient enrollment.
Recently, Delcath Systems announced that the first patient was enrolled under the amended protocol for its registration trial in ocular melanoma liver metastases. Stanford University Medical Center is the first trial site to enroll a patient under the amended protocol.
Delcath Systems, Inc. (DCTH), closed Tuesday's trading session at $0.260285, down 1.41%, on 78,670 volume with 58 trades. The average volume for the last 3 months is 180,680 and the stock's 52-week low/high is $0.23/$10.75.
Blue Line Protection Group, Inc. (BLPG)
AwesomePennyStocks, Barchart, New Cannabis Ventures, Marijuana Stocks, Stockwolf, Marketwired, and cannabiznetwork reported on Blue Line Protection Group, Inc. (BLPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Blue Line Protection Group, Inc. provides consulting, armed security, compliance and investigations, transportation, and secure vaulting services to banks, businesses and government entities. Its professional team consists mainly of former military and law enforcement personnel with decades of experience in protection, investigations, logistics, and tactical industries. Established in 2006, Blue Line Protection Group is based in Denver, Colorado.
The Company works side-by-side with retail establishments. Blue Line decreases the risk of criminal activity and creates a secure retail experience through protecting businesses on-site and securing their assets on the road.
Blue Line helps retailers remain compliant with all applicable laws. Furthermore, it shows retail establishments how to protect their businesses through letting Blue Line assume the responsibility and liability for their protective services.
Blue Line serves banks and credit unions through providing currency processing and transportation solutions. Its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates.
The Company acts on behalf of banks and credit unions through collecting cash sales revenue from their client locations. Upon collecting the currency, Blue Line transports it to one of its secure processing facilities. It provides currency handling and validation services for the bank and transportation of processed currency to the Federal Reserve.
Blue Line Protection Group and Hypur have plans to open a cash vaulting and processing facility to serve marijuana-related businesses (MRBs) and cash-intensive businesses (CIBs) in Nevada. Blue Line plans to partner with Hypur to expand services to Arizona, Oregon, Washington, California and Nevada.
The new Nevada facility will implement “Hypur Vault” cash management technologies. Hypur Vault provides cash custody management tools. Hypur is a financial technology (FinTech) company based in Scottsdale, Arizona.
Blue Line Protection Group continues to advance its plans for deploying cash vaulting and compliance investigations services in Nevada. This is to serve the needs of the legal cannabis industry.
Blue Line’s plan is to provide secure vaulting services for cannabis clients, and cash validation and investigations services to help ease the transition to complete banking services for its cash vaulting clients as financial institutions begin serving the industry.
Blue Line Protection Group, Inc. (BLPG), closed Tuesday's trading session at $0.0015, down 6.25%, on 11,645,130 volume with 52 trades. The average volume for the last 3 months is 5,557,791 and the stock's 52-week low/high is $0.001/$0.105.
Table Trac, Inc. (TBTC)
NetworkNewsWire, Penny Stock Tweets, MarketWatch, OTC Markets, Wallet Investor, Stockhouse, BUYINS.NET, Marketbeat, FeedBlitz, Market Exclusive, M2 Communications and Investors Hangout reported on Table Trac, Inc. (TBTC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Table Trac, Inc. is a developer and provider of casino information and management systems. These systems automate and monitor the operations of casinos. The Company has systems installed in North America, South America, Central America, and the Caribbean. OTCQB-listed, Table Trac is headquartered in Minnetonka, Minnesota. It also has a South America office in Envigado, Colombia.
The TableTrac™ table games management system is a patented solution. TableTrac™ provides table games managers and gaming operators with all the modules needed to manage and run a table games Pit. These include modules from credit fills and reporting to patron management and promotions.
The CasinoTrac™ casino management system provides a complete set of all the modules necessary to ensure floor operations, real-time floor monitoring, daily revenue auditing, and managerial accounting and players club operations for any size casino.
The design of Table Trac’s KioskTrac™ is to reward play and increase visitation. KioskTrac™ provides operators with a vehicle to drive revenues. This is from “text-to-win” and campaigns, to email and direct mail.
In 2017, Table Trac signed 13 new customer contracts. The Company delivered its first systems in Maryland and Nevada. At the end of 2017, Table Trac had casino management systems, table games management systems and ancillary products installed with continuing support and maintenance contracts with 86 casino operators in greater than 130 casinos around the world.
The Sauk Suiattle C.C. of Washington, who are opening their first casino, recently selected Table Trac's CasinoTrac system to be their casino management system of choice.
Mr. Chad Hoehne, Table Trac’s President, said, "I am very pleased to be partnering with the Sauk Suiattle C.C and am very happy to have them join our casino system customers. We are dedicated to making our system easy to use and easy to own, with a commitment to service and value."
Recently, Table Trac announced financial results for the quarter ending June 30, 2018. The Company delivered five systems during the quarter. Revenues increased from $2,183,787 in 2017 to $3,003,135 in 2018.
Gross Margin for Q2 of 2018 was $1,196,531 versus $753,931 in 2017. Net Income for 2018 was $410,538 versus Net Income of $164,988 for 2017.
Table Trac, Inc. (TBTC), closed Tuesday's trading session at $2.55, up 2.00%, on 3,229 volume with 4 trades. The average volume for the last 3 months is 521 and the stock's 52-week low/high is $1.50/$3.40.
SANUWAVE Health, Inc. (SNWV)
Marketbeat.com, RedChip, TopPennyStockMover, SmallCapVoice, PennyStocks24, OTC Stock Review, Penny Stock Rumble, Streetwise Reports, The Green Baron, Greenbackers, OTCJournal, FeedBlitz, AllPennyStocks, OTC Stock Review, Explicit Penny Picks, Free Investment Report, Free Penny Alerts, Gladiator Stocks, InsidersLab, KillerPennyStocks, and Ox of Wallstreet reported on SANUWAVE Health, Inc. (SNWV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
SANUWAVE Health, Inc. is a shock wave technology business. Its initial focus is on the development and commercialization of patented non-invasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE Health researches, designs, manufactures, markets and services its products internationally. SANUWAVE Health is headquartered in Suwanee, Georgia.
The Company applies its patented Pulsed Acoustic Cellular Expression (PACE®) technology in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac conditions. Its portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses. This produces new vascularization and microcirculatory improvement. This helps in restoring the body's normal healing processes and leads to regeneration of tissue.
SANUWAVE’s lead product candidate for the global wound care market, dermaPACE®, is CE marked across Europe. It has Canada, Australia, and New Zealand device license approval for the treatment of skin and subcutaneous soft tissue. In the U.S., dermaPACE is now under the Food and Drug Administration's (FDA's) de novo petition review process for the treatment of diabetic foot ulcers. Diabetic foot ulcer treatment additionally has approval in South Korea.
SANUWAVE’s belief is that it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) via its U.S. Class III PMA approved OssaTron® device, and also stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the use of its OssaTron, Evotron® and orthoPACE® devices in Europe, Asia, and Asia/Pacific. Moreover, there are license/partnership opportunities for the Company’s shock wave technology for non-medical uses. This includes energy, water, food, and industrial markets.
In December of 2016, SANUWAVE Health announced that it, in partnership with Ortho-Medico, a member of B&Co, Herzele, Belgium, is sponsoring ongoing clinical investigation on diabetic foot ulcers (DFU). The trial will be conducted by the VUB (Free University of Brussels) and UZ Brussel (University Hospital).
Previous work in 2015 at this hospital found that DFU patients, treated in-home with the dermaPACE system, responded positively to the treatment. The trial will take the home-care procedures, used in a limited basis, and extend them to a randomized, controlled trial of 100 subjects. The intention of the trial is to compare the effectiveness of in-home treatment of DFUs utilizing dermaPACE versus in-home treatment of DFUs using standard of care only. The trial will help to provide evidence that dermaPACE can be used outside the clinical setting and increase the potential for increased sales in Europe.
SANUWAVE Health previously announced that the U.S. Patent and Trademark Office (USPTO) issued SANUWAVE patent number 9,566,209 titled "Shock Wave Electrodes with Fluid Holes", which has an expiration date on June 21, 2033. The patent relates to a new construction of the spark gap electrodes employed to generate acoustic pressure shock waves in the Company’s devices that allows a longer useful life for the applicators.
Recently, SANUWAVE Health announced that it is entering into a Memorandum of Understanding (MOU) with eKare, Inc. This is to develop novel wound care analysis and management solutions. Linking SANUWAVE's dermaPACE® wound treatment device with eKare's inSight® 3D wound imaging and analytics system, the two companies will work to produce the industry's most complete wound management solution. eKare’s commitment is to the design and development of wound assessment solutions utilizing the most contemporary machine intelligence, computer-vision, as well as mobile technology.
SANUWAVE Health, Inc. (SNWV), closed Tuesday's trading session at $0.169, up 0.12%, on 32,600 volume with 14 trades. The average volume for the last 3 months is 106,044 and the stock's 52-week low/high is $0.141/$0.642.
WRIT Media Group, Inc. (WRIT)
SeriousTraders, Tip.us, Real Pennies, StocksToBuyNow, Pennystockmania, Great Penny Picks, and SmallCapVoice reported earlier on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.
WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.
WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.
Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.
WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.
Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.
WRIT Media's development team has built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.
WRIT Media Group, Inc. (WRIT), closed Tuesday's trading session at $0.0299, up 98.01%, on 1,900 volume with 1 trade. The average volume for the last 3 months is 11,010 and the stock's 52-week low/high is $0.0099/$0.1598.
The QualityStocks Company Corner
- Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTC: MLNLF)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- SinglePoint, Inc. (SING)
- Marijuana Company of America Inc. (MCOA)
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
- Cyberfort Software, Inc. (CYBF)
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
- Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)
Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTC: MLNLF)
Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTCQX: MLNLF) was featured today in a “One to Watch” article, highlighting the numerous reasons for the Argentina-based company’s compelling valuation, which places it with a $123 million market cap, third only to Lithium Americas and Orocobre in the region.
Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTC: MLNLF) is engaged in the development of the Pastos Grandes lithium project in Salta Province, Argentina. The company’s Pastos Grandes project totals approximately 10,000 hectares located in geopolitically stable, mining-friendly jurisdictions. The company also enjoys a solid strategic partnership with GCL, a Chinese solar giant that has become Millennial Lithium’s lead investor with approximately $30 million investment to date.
Millennial Lithium’s compelling valuation places it with a $123 million market cap, third only to Lithium Americas and Orocobre in the region. The company holds a strong cash position of C$40 million and is pursuing a strategic plan moving forward in 2019 that includes an updated NI 43-101 resource report and a full bankable feasibility study, including supporting evaporation ponds and pilot processing plant.
Argentina currently produces 17 percent of the world’s lithium supply. Lithium is at the cornerstone of a quiet industrial revolution as it brings together energy, automotive and technologies companies to foster a lasting move away from carbon-based resources. Lithium demand is expected to grow at an annual rate of 22 percent through 2025 with increased demands for lithium-ion batteries used in electric vehicles and battery-based energy storage leading the way.
Millennial Lithium has a world-class lithium brine asset strategically located in the heart of the Argentinean portion of the South American “Lithium Triangle.”
The company’s flagship lithium brine project, Pastos Grandes, is following a two-year timeline to production as a result of some of the best infrastructure in the Lithium Triangle. Located 231 km from the city of Salta at an elevation of 3,800 meters, Pastos Grandes is accessible year-round with all-weather access to paved highways, power and natural gas. Based on proven technology, brine extraction, solar evaporation and conventional lithium brine processing, Millennial Lithium’s preliminary economic assessment (PEA) of the Pastos Grandes project, completed by international engineering firm WorleyParsons, estimates a mine life of 25 years with a three-year ramp up to 25,000 tonnes per year of Lithium-Carbonate. A 3 tonne-per-month lithium carbonate pilot plant is currently being built for use at the site.
To date, 23 exploration wells are completed with $40 million spent in development. A revised Resource Estimate is planned for Q1 2019. Four pumping wells are also to be completed in Q1 2019 with two water wells currently being drilled in support of the ongoing Feasibility Study, also being completed by WorleyParsons. Infrastructure buildup is underway, including completion of a 40-man camp, hybrid solar-diesel power system, pilot plant and laboratory with ICP unit for rapid sample assays and a liming plant for treating concentrated brines form the pilot ponds. Millennial Lithium is also constructing a Pastos Grandes community center/warehouse and all-purpose building that is central to building community relations with local residents.
Encouraging results from an extended pumping test of a second production-scale well at the Pastos Grandes project revealed that at a pumping rate of 15 liters/second (L/s), the lithium content remained consistent over the 23-day trial period with a drawdown of approximately 57 meters with rapid recovery. Estimated transmissivity (the rate at which the brine moves through the aquifer) is 40 square meters per day, demonstrating the aquifer’s strong potential to sustain a long-term pumping rate of 15 L/s.
Brine sampling completed daily during the pumping test over the 23-day period revealed the chemistry is consistent with lithium ranging from 482 mg/L and 518 mg/L, averaging 495 mg/L. The best lithium values occurred during the last five days of the pumping test. The magnesium to lithium (Mg/Li) ratio averages 5.3 and the average potassium to lithium ratio (K/Li) is 10.5 and the average sulphate to lithium ratio (SO4/Li) is 16.4. Sampling was conducted in accordance with CIM guidelines for brine resource evaluation, with an appropriate chain of custody and QA/QC program in place for ensuring veracity, accuracy and precision of the analytical results.
Millennial Lithium’s highly prospective lithium assets and strategies are bolstered by a world class management and board with extensive experience in lithium and large development projects.
President/CEO/Director Farhad Abasov, MBA, has founded and managed a number of mining aassets with successful exits in the last few years. He was president and CEO of Allana Potash which was sold to Israel Chemicals Ltd. for $170 million in 2015. As executive chairman of Rodinia Lithium, Abasov developed lithium bring projects in Argentina in 2016. He was also co-founder of Potash One, acquired by German potash company K+S for $430 million in 2010, and was senior vice president, strategy, at Energy Metals, acquired by Uranium One for $1.88 million in 2007.
Iain Scarr, BSc., MBA, is Chief Operating Officer with a wealth of experience in lithium brine development and operations. He worked at Rio Tinto, industrial minerals, including lithium resource development in Serbia. Scarr led feasibility work at Sal de Vida lithium brine project (Galaxy Resources, Argentina); completed the Rincon lithium brine project feasibility study (Enirgi, Argentina); and is a resident of Salta with established, strong relationships in the region.
Chief Financial Officer Max Missiouk, CPA, CMA, has served as a CFP and controller for a number of publicly listed resource and venture companies including Allana Potash Corp. and Crocodile Gold Corp. He is a CPA (CMA) and has a post-graduate degree in banking and finance management.
Peter J. MacLean, Ph.D., P.Geo, is senior vice president, technical services. He has more than 30 years of exploration and development experience in North America, South America and Africa. Most recently, MacLean acted as senior vice president/exploration of Allana Potash Corp. and directed all exploration and development activities on its flagship Danakhil Potash Project in Ethiopia including managing the company’s Feasibility Study and overseeing pilot solution mining and evaporation pond trials. He has also worked extensively on projects throughout the Americas and is fluent in Spanish.
Peter Ehren, M.Sc., AusIMM CP, process consultant, has been involved in lithium brines for more than 20 years. Ehren has worked at the Salar de Atacama as part of SQM’s team of leading evaporation technology experts, rising to the position of R&D manager. He has worked in the majority of lithium basins worldwide for numerous projects including Orocobre’s Salar de Olaroz Project.
Millennial Lithium Corp. (OTC: MLNLF), closed the day's trading session at $1.3467, up 2.80%, on 37,888 volume with 29 trades. The average volume for the last 3 months is 14,921 and the stock's 52-week low/high is $0.67/$2.86.
- Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTCQX: MLNLF) is “One to Watch”
- Millennial Reports Positive Pumping Test Results from Second Pumping Well at Pastos Grandes Project, Argentina
- Big Question Remains Will Lithium Supply Meet Its Demand
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products (CSE: PLUS) (OTCQB:PLPRF) (the “Company” or “Plus Products”), California’s top edible brand by market share according to BDS Analytics, today announced that it has begun to roll out child-resistant (CR) tins across the state, well in advance of a January 2020 California deadline. Also today, NetworkNewsWire released a report on the company detailing how Plus Products has expanded its leading position in California’s cannabis-infused edibles retail market, with the company now boasting three of the segment’s top five products, according to sales data from BDS Analytics (http://nnw.fm/DkCe2).
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed the day's trading session at $5.55, up 0.28%, on 18,783 volume with 73 trades. The average volume for the last 3 months is 105,064 and the stock's 52-week low/high is $2.81/$6.01.
- PLUS™ Redesigns Signature Tins and Delivers Popular Gummies in New Child-Resistant Packaging
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Extends Lead in California Cannabis-Infused Edibles Market with Best Sellers
- PLUS™ Products Interview Featured on Business Television (B-TV)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted in an article examining how CBD made headlines at the 2019 Academy Awards. In fact, actress Melissa McCarthy reportedly applied CBD oil to her feet to alleviate the pain she anticipated from high-heel shoes. In addition, according to Allure, stylist Kate Young also uses cannabis-based numbing cream with her celebrity clients, as well.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.07925, up 5.82%, on 2,088,279 volume with 2,940 trades. The average volume for the last 3 months is 968,849 and the stock's 52-week low/high is $1.607/$7.894.
- How the 2019 Academy Awards Rolled out the Carpet for CBD Stocks
- NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Increases Operating Capacity at Hamilton Facility
- The Green Organic Dutchman Provides Jamaican Operations Update
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ''Company'' or ''Lexaria''), a drug delivery platform innovator, comments on the February 21, 2019 U.S. Food & Drug Administration (''FDA") statement outlining the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes, and the FDA draft guidance issued: ''Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products''.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.
In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.4425, up 2.30%, on 82,871 volume with 124 trades. The average volume for the last 3 months is 188,804 and the stock's 52-week low/high is $0.75/$2.43.
- Lexaria Bioscience Comments on FDA Statement on Novel Nicotine Replacement Therapies
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Plans Additional Clinical Trials Following Successful Tests
- 420 with CNW – Four Ways Cannabis Entrepreneurs are Using AI in Sales and Ecommerce
SinglePoint, Inc. (SING)
SinglePoint (OTCQB:SING) a fully reporting technology company, is pleased to announce it has signed an asset purchase agreement to acquire Direct Solar and AI Live Transfers. The two companies are providing what has been described as the Lending Tree Model for solar business. With the proposal of The Green New Deal, solar is at the forefront of every conversation and will continue to be top of mind as the nation grows through an “energy shift” to renewable resources such as solar. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. While attempts to legalize cannabis by a ballot measure last year and by legislative means this month were met with defeat, marijuana advocates in the state aren’t giving up, and they are already planning to have another shot at a ballot measure in 2020.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed the day's trading session at $0.02, up 14.94%, on 17,171,459 volume with 608 trades. The average volume for the last 3 months is 6,065,410 and the stock's 52-week low/high is $0.0106/$0.0709.
- SinglePoint to Acquire the ‘Lending Tree’ of Solar, Doubling the Company’s Revenues Instantly
- 420 with CNW – North Dakota Cannabis Activists Consider 2020 Ballot Measure
- SinglePoint Inc. (SING) Kicks Off Busy 2019 with Investor Update, Expands Sales Team as CBD Product Inquiries Rise Following Farm Bill Passage
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (MCOA) is proud to announce that the United States Patent and Trademark Office issued the Company a patent for the formulation of its flagship CBD product, hempSMART™ Brain. Also today, the company was highlighted in an article examining the ever growing universe of CBD infused items.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.014, up 3.70%, on 14,191,543 volume with 480 trades. The average volume for the last 3 months is 13,931,642 and the stock's 52-week low/high is $0.0115/$0.049.
- Marijuana Company of America Issued Patent for hempSMART Brain
- Rise In New CBD Products Resulting In Increase In Patent Filings
- NetworkNewsBreaks — Marijuana Company of America Inc. (MCOA) Subsidiary Advances Brand Presence via Star-Studded Events
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) was featured today in the 420 with CNW by CannabisNewsWire. While attempts to legalize cannabis by a ballot measure last year and by legislative means this month were met with defeat, marijuana advocates in the state aren’t giving up, and they are already planning to have another shot at a ballot measure in 2020.
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.
As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.
The central components of the company’s business strategy are:
- Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
- Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.
Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.
Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.
The strategy employed by Redfund includes:
- Diversifying investments in Canada and other countries
- Building an international footprint with established national leaders
- Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
- Introducing companies to Canada as a viable option for public listings
- Becoming a premier go-to lender for established companies
The company’s revenue sources include:
- Interest-bearing debt instruments with asset-backed collateral to securitize loans
- Equity kicker of warrants coverage on original loan
- Conversion ability of loan in its entirety
- Advisory fees from contracts for consulting on growth strategies
- Right of first refusal on future financing in each company funded
Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.1873, even for the day. The average volume for the last 3 months is 210 and the stock's 52-week low/high is $0.10/$0.505.
- 420 with CNW – North Dakota Cannabis Activists Consider 2020 Ballot Measure
- NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Client Wildflower Brands Provides Swag for 2019 Oscars
- NetworkNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Expands Advisory Agreement with Wahupta Ventures to Include up to $1M Investment
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) is pleased to announce the appointment of Randy Whitaker as Chief Operating Officer, a new position within GGB. Mr. Whitaker has over 27 years' experience in real estate, finance, and store operations. Mr. Whitaker joins GGB from Belk, Inc. a privately held department store with over 293 locations.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.8702, off by 2.02%, on 287,554 volume with 568 trades. The average volume for the last 3 months is 197,540 and the stock's 52-week low/high is $1.8068/$5.205.
- Green Growth Brands Names Randy Whitaker Chief Operating Officer
- Green Growth Brands Opens CBD Shops in Indiana and Tennessee Malls
- Top Cannabis Stocks to Watch as Retailers Transform Beauty and Wellness Market
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) is strengthening its cannabis beverage and edibles supply operations as Canada, where it is based, proceeds from legalizing recreational cannabis use for adults last year to legally licensing cannabis edibles and beverages later this year.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.3094, off by 2.67%, on 205,215 volume with 106 trades. The average volume for the last 3 months is 280,410 and the stock's 52-week low/high is $0.189/$1.875.
- Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Builds Cannabis Might amid Preparations for Legal Beverage, Edibles Market
- Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Discusses Innovation and Expansion
- NetworkNewsBreaks – Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Solidifies Position in Cannabis Beverage Industry through Additions to Leadership Team
Cyberfort Software, Inc. (CYBF)
Cyberfort Software, Inc. (OTC: CYBF) the company was highlighted in an article examining how the major forces driving the cybersecurity market growth are strict data protection directives and rising cyber terrorism. The cybersecurity market is growing rapidly because of the rising need for cloud-based cybersecurity solutions among Small and Medium-sized Enterprises (SMEs).
Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.
Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.
The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.
Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.
“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.
Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.
As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.
The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.
Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.
Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.
Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.
Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.16, off by 15.79%, on 48,603 volume with 17 trades. The average volume for the last 3 months is 15,278 and the stock's 52-week low/high is $0.018/$42.00.
- Cyberfort Software, Inc. (OTC: CYBF) is Well Positioned for Future Growth in the Multibillion-Dollar Cybersecurity Industry
- NetworkNewsBreaks – Cyberfort Software Inc. (CYBF) Protects Against Cyberattacks as Vulnerability Rises with Advancements in Technology
- Cyberfort Software Inc. (CYBF) Tops List of Cybersecurity Stocks to Watch in 2019
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)
BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, this morning announced a non-brokered private placement financing of 5,000,000 of its common shares, each at a price of C$0.10, for gross proceeds of C$500,000. To view the full press release, visit: http://nnw.fm/GUaf1.
BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.
BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.
The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.
BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.
BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.
Breast Cancer Statistics
The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.
Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.
The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.
BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0747, off by 3.80%, on 2,200 volume with 4 trades. The average volume for the last 3 months is 19,734 and the stock's 52-week low/high is $0.0495/$0.135.
- NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Director to Invest C$500,000 in Private Placement Financing
- BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Announce Breast Cancer Immunotherapy Findings at Key Oncology Conferences
- BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences
Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)
Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.
Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).
Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.
Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.
The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.
Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.
The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.
Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.
Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.
Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.
Black Iron Inc. (BKIRF), closed the day's trading session at $0.065877, up 2.20%, on 130,718 volume with 13 trades. The average volume for the last 3 months is 26,108 and the stock's 52-week low/high is $0.0285/$0.0939.
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Holds Economic Advantage as Iron Ore Market Prices Face Worldwide Increase
- Investing in Election Season: The Polls to Watch in 2019 — Part 1
- Black Iron: Shymanivske Outshines Gloom of War
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.
Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.
Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.
Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.
Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.
“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”
Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.
Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.
Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.
Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.131, up 8.90%, on 32,462 volume with 7 trades. The average volume for the last 3 months is 22,673 and the stock's 52-week low/high is $0.0701/$0.5925.
- Pacific Rim Announces Non-Brokered Financing
- NetworkNewsAudio Announces Audio Press Release (APR) on Pacific Rim Cobalt Corp. Well Positioned in Hunt for Cobalt
- NetworkNewsWire Announces Publication on Multinational Companies and Industrialized Nations Working to Secure Critical Metals
Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)
Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.
Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.
As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.
Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.
Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.
Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:
- Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
- Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
- Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
- Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
- Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.
The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.
The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.
Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.
Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.61, up 1.67%, on 20,500 volume with 5 trades. The average volume for the last 3 months is 12,466 and the stock's 52-week low/high is $0.46/$1.27.
- Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) Sets 2019 Goals of Acquisitions, SaaS Sales Acceleration and Positive Cash Flow
- Kontrol Energy Announces U.S. Listing on OTCQB Market Under Symbol KNRLF
- Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) Joins Global Energy Efficiency Marketplace with Smartmax Smart Technology Offering
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) to Announce Breast Cancer Immunotherapy Findings at Key Oncology Conferences
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Holds Economic Advantage as Iron Ore Market Prices Face Worldwide Increase
- Cannabis Strategic Ventures, Inc. (NUGS) Expands Portfolio with Cannabis Brands around the World
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) 420 with CNW – Judge Faults Walmart in Arizona Medical Cannabis Case
- ChineseInvestors.com (CIIX) ‘opt’ Brand Features opt Hemp and opt2mist Hemp-Derived CBD Lines, Unifies Domestic Products
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Completes Buildout of E-Commerce Platform
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Cyberfort Software, Inc. (CYBF) Tops List of Cybersecurity Stocks to Watch in 2019
- Earth Science Tech, Inc. (ETST) Signs Distributor Agreements and Provides Updates on CBD Line
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Closes Convertible Debenture Financing Totaling $4.8 Million
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Appoints Three-Term Idaho Governor Butch Otter to its Board of Directors
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Selected as 2019 Edison Awards Finalist
- Generation Alpha, Inc. (GNAL) 420 with CNW – New York City Legislators Consider Banning Pre-Employment Cannabis Tests
- Global Payout, Inc. (GOHE) MTrac Subsidiary Launches New Website
- Golden Developing Solutions, Inc. (DVLP) Where’s Weed Platform Teams Up with Cannabis Point-of-Sale Resource GreenBits
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Opens CBD Shops in Indiana and Tennessee Malls
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Four Ways Cannabis Entrepreneurs are Using AI in Sales and Ecommerce
- Icon Exploration Inc. (TSX.V: IEX.H) to Delist from the TSX Venture Exchange
- Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) Sets 2019 Goals of Acquisitions, SaaS Sales Acceleration and Positive Cash Flow
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Plans Additional Clinical Trials Following Successful Tests
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Plans Second Program for Additional T.E.M and Follow Up Drilling on The Turi Prospect
- Marijuana Company of America Inc. (MCOA) Subsidiary Advances Brand Presence via Star-Studded Events
- Medical Cannabis Payment Solutions (REFG) 420 with CNW – Study Says Dabbing is the Most Efficient Way to Consume Cannabis
- MustGrow Biologics Corp. is “One to Watch”
- Net Element, Inc. (NASDAQ: NETE) 420 with CNW – Does Legalization of Recreational Marijuana Mark the Death of Medical Cannabis Programs
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Non-Brokered Financing
- Pacific Software, Inc. (PFSF) Partnership with Brazilian Trade Association Could Have Far-Reaching Impact for its BOAPIN Blockchain Trading Platform
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) Partners with Flora Research Laboratories for QA and Product Testing
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Interview Featured on Business Television (B-TV)
- Pressure BioSciences Inc. (PBIO) Scientific Analyses Confirm Important Benefits from Processing CBD Oil with Pressure BioSciences' Proprietary Ultra Shear Technology Platform
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Commences Drilling Program at Irgon Lithium Mine Project
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Client Wildflower Brands Provides Swag for 2019 Oscars
- Sharing Services, Inc. (SHRV) Expanding International Reach
- SinglePoint, Inc. (SING) Kicks Off Busy 2019 with Investor Update, Expands Sales Team as CBD Product Inquiries Rise Following Farm Bill Passage
- Spectrum Global Solutions, Inc. (SGSI) Receives Over $5.8 Million in New Contract Awards
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Discusses Innovation and Expansion
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Announces $10.5 Million Bought Deal
- Sugarmade, Inc. (SGMD) to Exercise Option to Acquire BZRTH, LLC Further Expanding its Presence in Cannabis Supplies Sector
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Reflects on Milestone Year of Revenue Growth and Industry Recognition
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Emphasis on Product Quality Positions the Flowr Corporation for Success as the Cannabis Sector Swells
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Increases Operating Capacity at Hamilton Facility
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Addressing Dermatological Needs with Premier Medical Devices
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) to Present at The Gravitas Growth Conference in Vancouver
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Hemp-CBD Infused Products Craze Picking Up Momentum for Canadian and U.S. Stocks
- Youngevity International, Inc. (NASDAQ: YGYI) Completes Acquisition of Assets of Khrysos Global, a Provider of End-to-End Processing Solutions for Hemp
- Zenergy Brands, Inc. (ZNGY) Completes Zero Cost Contract Installation with Franchisee of Well-Known Fast Food Restaurant Chain
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.